Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-841.53%
↓ 139% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-351.52%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -841.53% | +57.3% |
| 2024 | -1970.60% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |